Hoteles City Express. de Valuation
Is HCITY * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Sales gegen Gleichaltrige
Price-To-Sales gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of HCITY * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: HCITY * (MX$5.42) wird unter unserer Schätzung des Fair Value (MX$12.74) gehandelt.
Deutlich unter dem Marktwert: HCITY * wird um mehr als 20 % unter dem Marktwert gehandelt.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HCITY *?
Other financial metrics that can be useful for relative valuation.
| What is HCITY *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | Mex$2.07b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.9x |
| Enterprise Value/EBITDA | 6.5x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does HCITY *'s PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.4x | ||
CIDMEGA * Grupe. de | 0.7x | n/a | Mex$2.3b |
HOTEL * Grupo Hotelero Santa Fe. de | 0.9x | 8.1% | Mex$2.7b |
POSADAS A Grupo Posadas. de | 1.5x | n/a | Mex$14.3b |
RLH A RLH Properties. de | 2.6x | n/a | Mex$19.2b |
HCITY * Hoteles City Express. de | 0.6x | 5.5% | Mex$2.1b |
Price-To-Sales gegen Gleichaltrige: HCITY * ist ein guter Wert, wenn man sein Price-To-Sales Verhältnis (0.6x) mit dem Durchschnitt der anderen Unternehmen (1.3x) vergleicht.
Price to Earnings Ratio vs Industry
How does HCITY *'s PE Ratio compare vs other companies in the South American Hospitality Industry?
Price-To-Sales gegen Industrie: HCITY * ist aufgrund seines Price-To-Sales Verhältnisses (0.6x) im Vergleich zum South American Hospitality Branchendurchschnitt (1x) ein guter Wert.
Price to Sales Ratio vs Fair Ratio
What is HCITY *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.6x |
| Fair PS Ratio | 0.5x |
PM vs. Fair Ratio: HCITY * ist teuer auf der Grundlage des Verhältnisses Price-To-Sales (0.6x) im Vergleich zum geschätzten fairen Verhältnis Price-To-Sales (0.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$4.99 | Mex$8.50 +70.3% | 29.4% | Mex$11.00 | Mex$6.00 | n/a | 2 |
| Mar ’25 | Mex$4.95 | Mex$8.50 +71.7% | 29.4% | Mex$11.00 | Mex$6.00 | n/a | 2 |
| Feb ’25 | Mex$5.46 | Mex$8.50 +55.7% | 29.4% | Mex$11.00 | Mex$6.00 | n/a | 2 |
| Dec ’24 | Mex$5.55 | Mex$10.00 +80.2% | 10.0% | Mex$11.00 | Mex$9.00 | n/a | 2 |
| Nov ’24 | Mex$5.62 | Mex$10.00 +77.9% | 10.0% | Mex$11.00 | Mex$9.00 | n/a | 2 |
| Oct ’24 | Mex$6.81 | Mex$10.00 +46.8% | 10.0% | Mex$11.00 | Mex$9.00 | n/a | 2 |
| Sep ’24 | Mex$6.93 | Mex$10.00 +44.3% | 10.0% | Mex$11.00 | Mex$9.00 | n/a | 2 |
| Aug ’24 | Mex$6.84 | Mex$10.00 +46.2% | 10.0% | Mex$11.00 | Mex$9.00 | n/a | 2 |
| Jul ’24 | Mex$7.17 | Mex$9.50 +32.5% | 5.3% | Mex$10.00 | Mex$9.00 | n/a | 2 |
| Jun ’24 | Mex$7.99 | Mex$9.50 +18.9% | 5.3% | Mex$10.00 | Mex$9.00 | n/a | 2 |
| May ’24 | Mex$8.29 | Mex$9.50 +14.6% | 5.3% | Mex$10.00 | Mex$9.00 | n/a | 2 |
| Apr ’24 | Mex$8.50 | Mex$9.50 +11.8% | 5.3% | Mex$10.00 | Mex$9.00 | Mex$5.09 | 2 |
| Mar ’24 | Mex$8.33 | Mex$9.50 +14.0% | 5.3% | Mex$10.00 | Mex$9.00 | Mex$4.95 | 2 |
| Feb ’24 | Mex$7.75 | Mex$7.50 -3.2% | 33.3% | Mex$10.00 | Mex$5.00 | Mex$5.46 | 2 |
| Jan ’24 | Mex$8.43 | Mex$7.50 -11.0% | 33.3% | Mex$10.00 | Mex$5.00 | Mex$5.93 | 2 |
| Dec ’23 | Mex$6.66 | Mex$7.50 +12.6% | 33.3% | Mex$10.00 | Mex$5.00 | Mex$5.55 | 2 |
| Nov ’23 | Mex$5.38 | Mex$7.50 +39.4% | 33.3% | Mex$10.00 | Mex$5.00 | Mex$5.62 | 2 |
| Oct ’23 | Mex$3.57 | Mex$8.50 +138.1% | 17.6% | Mex$10.00 | Mex$7.00 | Mex$6.81 | 2 |
| Sep ’23 | Mex$3.71 | Mex$8.50 +129.1% | 17.6% | Mex$10.00 | Mex$7.00 | Mex$6.93 | 2 |
| Aug ’23 | Mex$3.84 | Mex$8.50 +121.4% | 17.6% | Mex$10.00 | Mex$7.00 | Mex$6.84 | 2 |
| Jul ’23 | Mex$3.95 | Mex$8.50 +115.2% | 17.6% | Mex$10.00 | Mex$7.00 | Mex$7.17 | 2 |
| Jun ’23 | Mex$4.06 | Mex$8.50 +109.4% | 17.6% | Mex$10.00 | Mex$7.00 | Mex$7.99 | 2 |
| May ’23 | Mex$4.99 | Mex$8.50 +70.3% | 17.6% | Mex$10.00 | Mex$7.00 | Mex$8.29 | 2 |
| Apr ’23 | Mex$5.26 | Mex$9.75 +85.4% | 2.6% | Mex$10.00 | Mex$9.50 | Mex$8.50 | 2 |
Analysten-Prognose: Das Kursziel liegt mehr als 20% über dem aktuellen Aktienkurs, aber es gibt nicht genügend Analysten, die die Aktie beobachten, um eine statistische Sicherheit für eine Übereinstimmung zu ermitteln.